137 related articles for article (PubMed ID: 3801141)
1. [Assessment of the endocrine status of peptic ulcer patients being treated with dalargin].
Bulgakov SA; Bogdanov AN; Ovtrakht N; Pavlov SA
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):70-1. PubMed ID: 3801141
[No Abstract] [Full Text] [Related]
2. [Gastrointestinal endocrine cells during the treatment of duodenal ulcer patients with the new peptide preparation dalargin].
Zverkov IV; Arndt IP; Shcherbakova NV; Smagin VG
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):72-4. PubMed ID: 2879547
[No Abstract] [Full Text] [Related]
3. [Effect of the intravenous infusion of dalargin on biochemical and hormonal indices in the blood of patients with duodenal peptic ulcer].
Sokolov AS; Dmitrieva OF; Tishchenko VA
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):68-70. PubMed ID: 3801140
[No Abstract] [Full Text] [Related]
4. [Treatment of peptic ulcer hemorrhage with leucine enkephalin analog dalargin].
Georgadze AK; Fomin VB; Bulgakov SA; Fedenko VV
Khirurgiia (Mosk); 1990 Mar; (3):39-43. PubMed ID: 2193190
[TBL] [Abstract][Full Text] [Related]
5. [Anti-ulcer action and peripheral opioid activity of the products of dalargin degradation].
Polonskiĭ VM; Korobov NV
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):83-6. PubMed ID: 3026418
[No Abstract] [Full Text] [Related]
6. [Evaluation of the effectiveness of dalargin in treating exacerbated peptic ulcer under outpatient conditions at medical health units].
El'bov PV
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):65-7. PubMed ID: 3801138
[No Abstract] [Full Text] [Related]
7. [Use of a dalargin aerosol in treating the exacerbations of uncomplicated duodenal peptic ulcer].
Buglak NP; Bogdanov NN; Vinogradov VA; Titov MI
Vopr Kurortol Fizioter Lech Fiz Kult; 1988; (4):19-25. PubMed ID: 3195111
[No Abstract] [Full Text] [Related]
8. [Effect of the hexapeptide dalargin on ornithine decarboxylase activity in the duodenal mucosa of rats in experimental duodenal ulcer].
Iarygin KN; Shitin AG; Polonskiĭ VM; Vinogradov VA
Biull Eksp Biol Med; 1987 Mar; 103(3):319-21. PubMed ID: 3828514
[TBL] [Abstract][Full Text] [Related]
9. [Effect of dalargin on the level of gastric secretion].
Tepliuk SG
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):67-8. PubMed ID: 3801139
[No Abstract] [Full Text] [Related]
10. [The synthetic peptide preparation dalargin in the treatment of peptic ulcer].
Smagin VG; Vinogradov VA; Bulgakov SA; Propisnova EP; Titov MI
Ter Arkh; 1987; 59(2):44-8. PubMed ID: 3554590
[TBL] [Abstract][Full Text] [Related]
11. [Dalargin--the most active synthetic analog of endogenous opioids for treating peptic ulcer (the results of a 5-year search)].
Vinogradov VA; Polonskiĭ VM
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):62-3. PubMed ID: 3801137
[No Abstract] [Full Text] [Related]
12. [Clinical approval of dalargin--a new agent for treating peptic ulcer].
Smagin VG; Titov MI; Bulgakov SA; Propisnova EP
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):63-5. PubMed ID: 3541964
[No Abstract] [Full Text] [Related]
13. [Evaluation of the effectiveness of anti-ulcer preparations (dalargin, gastrocepin, solcoseryl) in the ambulatory treatment of peptic ulcer].
Bulgakov SA; El'bov PV; Vinogradov VA
Klin Med (Mosk); 1988 Jan; 66(1):84-6. PubMed ID: 3283442
[No Abstract] [Full Text] [Related]
14. [The efficacy of treating peptic ulcer patients with trichopol and dalargin].
Lukash NV; Buglak NP; Kriuchkova ON; Lukash SN; Maloshenko SI
Lik Sprava; 1992 Feb; (2):35-7. PubMed ID: 1441328
[TBL] [Abstract][Full Text] [Related]
15. [Receptor characteristics of the duodenal mucosa in peptic ulcer: a new approach to the individual selection of the therapy].
Pavlov SA; Vinogradov VA; Iarygin KN; Shugurov VA; Bogdanov AN
Ter Arkh; 1989; 61(2):24-7. PubMed ID: 2543094
[TBL] [Abstract][Full Text] [Related]
16. [Gastrin, gamma-endorphin and somatostatin cells of the stomach and duodenum in patients with duodenal ulcer treated with dalargin].
Zverkov IV; Vinogradov VA; Bulgakov SA; Smagin VG; Shcherbakova NV
Ter Arkh; 1987; 59(2):48-53. PubMed ID: 2437665
[TBL] [Abstract][Full Text] [Related]
17. [Dalargin electrophoresis as a method of treatment in duodenal ulcer].
Buglak NP; Bogdanov NN; Lukash SN; Vinogradov VA; Bogdanov AN
Klin Med (Mosk); 1988 Jan; 66(1):78-81. PubMed ID: 3283441
[No Abstract] [Full Text] [Related]
18. [The use of dalargin for treating duodenal peptic ulcer recurrences on an outpatient basis].
Buglak NP; Grigorenko EI; Dudar' LV
Lik Sprava; 1994; (7-8):121-3. PubMed ID: 7900332
[No Abstract] [Full Text] [Related]
19. [Endonasal electrophoresis of dalargin in the therapy of multiple and giant duodenal ulcers].
Buglak NP; Kostiukova EA; Asanova LK; Moshko IuA
Lik Sprava; 2003 Dec; (8):102-3. PubMed ID: 14965021
[TBL] [Abstract][Full Text] [Related]
20. [Effect of the peripheral administration of dalargin on ornithine decarboxylase activity in the duodenal mucosa of rats with experimental duodenal ulcers].
Iarygin KN; Shitin AG; Polonskiĭ VM; Moskovkin GN
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):76-8. PubMed ID: 3801143
[No Abstract] [Full Text] [Related]
[Next] [New Search]